Members access detailed storage guides, evidence-based protocols, and a community of thousands who have navigated these exact questions
In addition, Ascendis could receive up to $77.5 million for each additional drug developed
A MIPS eligible clinician with a score of zero receives a payment adjustment factor equal to the negative of the applicable percent as defined at defined at 414.1405, meaning that all MIPS eligible clinicians are potentially subject to a maximum downside risk equivalent to the applicable percent
Compounding pharmacies, like Compounding Center of Wisconsin, create personalized medications from scratch, allowing for adjustments in strength, ingredients, and form for optimal results
In our previous study, we demonstrated the decrease of amiodarone cytotoxicity using antioxidants in cell culture [3]
The Most Promising Libido-Restoring Peptide PT-141 (Bremelanotide) PT-141 works completely differently than Viagra or Cialis